Insider Transactions in Q2 2021 at Chemed Corp (CHE)
Insider Transaction List (Q2 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 17
2021
|
Thomas P Rice |
SELL
Open market or private sale
|
Direct |
841
-13.95%
|
$388,542
$462.47 P/Share
|
Jun 17
2021
|
Spencer S Lee executive vice president |
SELL
Bona fide gift
|
Direct |
1,982
-7.41%
|
-
|
Jun 11
2021
|
David Patrick Williams executive vice president & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,113
-18.17%
|
$2,958,692
$484.64 P/Share
|
Jun 11
2021
|
David Patrick Williams executive vice president & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,384
+23.59%
|
$1,401,840
$135.85 P/Share
|
Jun 11
2021
|
Nicholas Michael Westfall Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,708
+26.59%
|
$625,548
$231.91 P/Share
|
Jun 10
2021
|
Nicholas Michael Westfall Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,289
+32.43%
|
$528,759
$231.91 P/Share
|
Jun 09
2021
|
Nicholas Michael Westfall Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,482
+37.4%
|
$342,342
$231.91 P/Share
|
Jun 08
2021
|
Nicholas Michael Westfall Executive Vice President |
SELL
Open market or private sale
|
Direct |
2,708
-73.05%
|
$1,313,380
$485.04 P/Share
|
Jun 07
2021
|
Nicholas Michael Westfall Executive Vice President |
SELL
Open market or private sale
|
Direct |
2,289
-38.18%
|
$1,117,032
$488.55 P/Share
|
Jun 04
2021
|
Nicholas Michael Westfall Executive Vice President |
SELL
Open market or private sale
|
Direct |
1,482
-19.82%
|
$741,000
$500.12 P/Share
|
Jun 04
2021
|
Kevin J Mcnamara president and CEO |
SELL
Open market or private sale
|
Direct |
3,000
-2.23%
|
$1,491,000
$497.61 P/Share
|
May 17
2021
|
Ron De Lyons |
BUY
Grant, award, or other acquisition
|
Direct |
270
+32.97%
|
$130,140
$482.66 P/Share
|
May 17
2021
|
Joel F Gemunder Director |
BUY
Grant, award, or other acquisition
|
Direct |
270
+1.19%
|
$130,140
$482.66 P/Share
|
May 17
2021
|
Patrick P Grace |
BUY
Grant, award, or other acquisition
|
Direct |
270
+7.07%
|
$130,140
$482.66 P/Share
|
May 17
2021
|
Christopher J Heaney |
BUY
Grant, award, or other acquisition
|
Direct |
270
+17.51%
|
$130,140
$482.66 P/Share
|
May 17
2021
|
Andrea R Lindell |
BUY
Grant, award, or other acquisition
|
Direct |
270
+4.51%
|
$130,140
$482.66 P/Share
|
May 17
2021
|
Thomas P Rice |
BUY
Grant, award, or other acquisition
|
Direct |
270
+4.29%
|
$130,140
$482.66 P/Share
|
May 17
2021
|
Donald E Saunders Director |
BUY
Grant, award, or other acquisition
|
Direct |
270
+3.99%
|
$130,140
$482.66 P/Share
|
May 17
2021
|
George J Walsh Iii |
BUY
Grant, award, or other acquisition
|
Direct |
270
+8.79%
|
$130,140
$482.66 P/Share
|
May 06
2021
|
Thomas C Hutton vice president |
SELL
Bona fide gift
|
Direct |
911
-2.63%
|
-
|
May 05
2021
|
Kevin J Mcnamara president and CEO |
SELL
Open market or private sale
|
Direct |
3,000
-2.18%
|
$1,431,000
$477.37 P/Share
|
May 05
2021
|
Kevin J Mcnamara president and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,809
-2.0%
|
$1,359,556
$484.12 P/Share
|
May 05
2021
|
Kevin J Mcnamara president and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+2.77%
|
$924,000
$231.91 P/Share
|
May 03
2021
|
George J Walsh Iii |
SELL
Open market or private sale
|
Direct |
626
-19.82%
|
$300,480
$480.31 P/Share
|